Innodata (INOD)
Builds training data, evaluations, safety programs, and deployment workflows for advanced AI systems.
Something off on this page? Send us feedback.
Develops training and post-training data, model evaluations, safety programs, and deployment workflows for AI builders and enterprise adopters, supplemented by Synodex healthcare-data and Agility media-intelligence software. Revenue comes primarily from project-based services for U.S. customers and is concentrated in two large accounts.
Builds training and post-training datasets, model evaluations, alignment and safety programs, and deployment workflows for advanced AI systems. Synodex turns medical records into structured data for insurance and healthcare processes, while Agility supplies media intelligence and public-relations workflow software. These offerings now sit within one reportable segment.
Combines proprietary workflow tools, automation, quality controls, and specialist human judgment to run repeatable data and evaluation programs. Delivery uses a globally distributed workforce across Asia, North America, and Europe, while customers are predominantly in the United States. Revenue is concentrated in two large customers, and project-based agreements generally provide no committed future volume and can be terminated on short notice.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Jun 4, 2026 | Wedbush | Reiterate | Rating: —Target: $90 | Target: $120 |
| Jan 5, 2026 | BWS Financial | Upgrade | ||
| Oct 15, 2025 | Wedbush | Reiterate | Rating: —Target: $48 | Target: $90 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $250.4M · Total debt $15.0M · Total assets $356.7M · Shareholders' equity $159.5M
- Revenue
- $92.1M
- Operating income
- $15.9M
- Net income
- $14.4M
No dividends on record.
| Institutions | 57.91% | 19.91M shares | |
|---|---|---|---|
| 311 holders · as of Jun 30, 2026 | |||
| Insiders | 9.11% | 3.13M shares | |
| 11 holders · as of Sep 15, 2026 | |||
| Other | 32.98% | 11.34M shares | |
| remainder | |||
34.38M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
BlackRock, Inc.Institution | 7.90% | 2.72M | as of Jun 30, 2026 |
Nick ToorInsider | 4.29% | 1.47M | filed Nov 30, 2017 |
Vanguard Capital Management LLCInstitution | 4.04% | 1.39M | as of Jun 30, 2026 |
Jack AbuhoffInsiderdirector, officer: CEO | 3.90% | 1.34M | filed Jun 16, 2026 |
Jane Street Group, LLCInstitution | 3.71% | 1.27M | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Sep 14, 2026 | Louise C. Forlenza | director | −10,000 | $53.54 |
| Sep 4, 2026 | Louise C. Forlenza | director | −10,000 | $55.01 |
| Jun 15, 2026 | Jack Abuhoff | director, officer: CEO | −94,059 | $105.70 |
| Jun 16, 2026 | Jack Abuhoff | director, officer: CEO | −200,000 | $110.20 |
| Jun 2, 2026 | Ashok Mishra | officer: EVP and COO | −38,666 | $114.34 |
- TaskUs
AI services and trust operations overlap with DDS workflows
- TELUS
Owned TELUS Digital overlaps in AI data, CX, and trust operations
- ExlService
Data, AI, and digital operations overlap in insurance and healthcare
- Sprinklr
AI-native social listening and media intelligence overlap
- Quest Diagnostics
ExamOne overlaps in life-insurance health data workflows
- RELX (ADR)
Insurance risk analytics overlap with Synodex-adjacent data work
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Innodata | $63.39 | +3.83% | $1.99B | 46.2 | 59.8 | 6.3 | +57.8% |
| TaskUs | $8.43 | −2.56% | $780.3M | 7.5 | 6.1 | 0.6 | +5.0% |
| TELUS | $8.65 | −0.35% | $13.55B | — | 23.3 | 0.9 | −7.0% |
| ExlService | $34.83 | −1.22% | $5.35B | 22.2 | 14.5 | 2.4 | +15.6% |
| Sprinklr | $5.30 | −1.76% | $1.33B | 57.3 | 10.4 | 1.5 | +0.8% |
| Quest Diagnostics | $233.68 | −4.57% | $27.03B | 26.0 | 20.4 | 2.3 | +10.2% |
| RELX (ADR) | $32.95 | −1.38% | $58.33B | 20.2 | — | 4.5 | +1.0% |
| Median | 22.2 | 14.5 | 1.9 | +3.0% |